Wayne Winegarden
Business & Economics
NEW STUDY: Competitive Markets Reduce Electricity Costs, Improve Reliability, Lower Emissions
States with competitive electricity markets saw cheaper energy prices, more energy infrastructure investment to improve efficiency and reliability, and greater emission reductions compared to monopoly states, finds a new study released today by the nonpartisan Pacific Research Institute, a California-based, free-market think tank. “Residents and businesses lose out when states ...
Wayne Winegarden
March 28, 2022
Business & Economics
Rent control in response to rising housing costs? Wayne Winegarden responds on NTD News
Is enacting rent control measures a positive approach to dramatically rising housing costs? Watch economist and PRI senior fellow Wayne Winegarden respond below.
Wayne Winegarden
March 15, 2022
Blog
AB 5 is Taking Away Opportunities for Communities of Color & Low-Income Communities
Editor’s Note: On Monday, Dr. Wayne Winegarden, PRI senior fellow in Business and Economics, was invited to testify before the California advisory committee to the U.S. Commission on Civil Rights on the civil rights implications of California’s controversial AB 5. Winegarden’s comments as written are presented below: Madam/Mister Chairperson, members ...
Wayne Winegarden
March 9, 2022
Business & Economics
The Expanding Broadband Infrastructure Is A Private Sector Success Story
Recent data on prices provides important perspective regarding the $65 billion that Congress and President Biden will now spend on broadband infrastructure over the next ten years. According to the White House, the purpose of these expenditures is to help ensure that every American has access to reliable high-speed internet through ...
Wayne Winegarden
March 2, 2022
Health Care
The Flawed Third-Party Payer System Drives the Drug Affordability Problem
CLICK TO READ THE REPORT The problem of drug affordability is caused by the perverse incentives created by the third-party payer system that have disempowered patients in favor of insurers and other supply-chain intermediaries. The insurance flaws have created pricing systems that inequitably transfer a disproportionate share of drug costs ...
Wayne Winegarden
February 28, 2022
Commentary
Violating Manufacturer’s Property Rights Does Not Promote Healthy Competition
Too often, regulations undermine the competitive process in the name of promoting competition. The ill-conceived Right to Repair legislation exemplify the problems and risks. Under the pretense of promoting competition, states as diverse as Texas and California, Arkansas and Hawaii have all considered bills that would violate medical device companies’ intellectual property rights. While many have been defeated, ...
Wayne Winegarden
February 28, 2022
Business & Economics
NEW STUDY: Bad Policy Choices Zap Californians with $1450 Average Electricity Bills
Californians are being zapped with higher electricity bills – averaging $1450 per year – thanks to state government energy regulations, taxes, and subsidies, finds a new report released today by the nonpartisan Pacific Research Institute. Repealing or reforming these costly policies could save the average household $517 per year, ...
Wayne Winegarden
February 2, 2022
Commentary
Drug discount program padding hospital profits
Improving vulnerable populations’ access to medicines is clearly important. But something is amiss when a program that is supposed to improve access to healthcare has turned into a cash cow for hospitals. Yet, that is what has happened to the obscure 340B drug discount program. Too many hospitals across Massachusetts ...
Wayne Winegarden
January 31, 2022
Commentary
Comprehensive Regulatory Reform From The Bottom Up: The Case Of 340B
Using the ruse of “price negotiation”, the proponents of the Build Back Better legislation are pushing an ill-fated drug price control plan. Patients will bear exceptionally large costs should their idea of government-directed prices become law. These costs will include lower health outcomes due to reduced access to innovative drugs. ...
Wayne Winegarden
December 13, 2021
Blog
Inflation, Drug Price Controls, and President Biden’s Build Back Better Program
Inflation is worrying Americans, and for good reason. The latest inflation report, the Consumer Price Index (CPI) released on November 10th, showed that prices were 6.2 percent higher in October 2021 compared to October 2020. More troubling, this was the fifth month in a row where the annual growth in ...
Wayne Winegarden
November 12, 2021
NEW STUDY: Competitive Markets Reduce Electricity Costs, Improve Reliability, Lower Emissions
States with competitive electricity markets saw cheaper energy prices, more energy infrastructure investment to improve efficiency and reliability, and greater emission reductions compared to monopoly states, finds a new study released today by the nonpartisan Pacific Research Institute, a California-based, free-market think tank. “Residents and businesses lose out when states ...
Rent control in response to rising housing costs? Wayne Winegarden responds on NTD News
Is enacting rent control measures a positive approach to dramatically rising housing costs? Watch economist and PRI senior fellow Wayne Winegarden respond below.
AB 5 is Taking Away Opportunities for Communities of Color & Low-Income Communities
Editor’s Note: On Monday, Dr. Wayne Winegarden, PRI senior fellow in Business and Economics, was invited to testify before the California advisory committee to the U.S. Commission on Civil Rights on the civil rights implications of California’s controversial AB 5. Winegarden’s comments as written are presented below: Madam/Mister Chairperson, members ...
The Expanding Broadband Infrastructure Is A Private Sector Success Story
Recent data on prices provides important perspective regarding the $65 billion that Congress and President Biden will now spend on broadband infrastructure over the next ten years. According to the White House, the purpose of these expenditures is to help ensure that every American has access to reliable high-speed internet through ...
The Flawed Third-Party Payer System Drives the Drug Affordability Problem
CLICK TO READ THE REPORT The problem of drug affordability is caused by the perverse incentives created by the third-party payer system that have disempowered patients in favor of insurers and other supply-chain intermediaries. The insurance flaws have created pricing systems that inequitably transfer a disproportionate share of drug costs ...
Violating Manufacturer’s Property Rights Does Not Promote Healthy Competition
Too often, regulations undermine the competitive process in the name of promoting competition. The ill-conceived Right to Repair legislation exemplify the problems and risks. Under the pretense of promoting competition, states as diverse as Texas and California, Arkansas and Hawaii have all considered bills that would violate medical device companies’ intellectual property rights. While many have been defeated, ...
NEW STUDY: Bad Policy Choices Zap Californians with $1450 Average Electricity Bills
Californians are being zapped with higher electricity bills – averaging $1450 per year – thanks to state government energy regulations, taxes, and subsidies, finds a new report released today by the nonpartisan Pacific Research Institute. Repealing or reforming these costly policies could save the average household $517 per year, ...
Drug discount program padding hospital profits
Improving vulnerable populations’ access to medicines is clearly important. But something is amiss when a program that is supposed to improve access to healthcare has turned into a cash cow for hospitals. Yet, that is what has happened to the obscure 340B drug discount program. Too many hospitals across Massachusetts ...
Comprehensive Regulatory Reform From The Bottom Up: The Case Of 340B
Using the ruse of “price negotiation”, the proponents of the Build Back Better legislation are pushing an ill-fated drug price control plan. Patients will bear exceptionally large costs should their idea of government-directed prices become law. These costs will include lower health outcomes due to reduced access to innovative drugs. ...
Inflation, Drug Price Controls, and President Biden’s Build Back Better Program
Inflation is worrying Americans, and for good reason. The latest inflation report, the Consumer Price Index (CPI) released on November 10th, showed that prices were 6.2 percent higher in October 2021 compared to October 2020. More troubling, this was the fifth month in a row where the annual growth in ...